Press Release: PreciseDx : PreciseDx to Present on AI-enabled Breast Cancer Grade and Phenotyping Assay at United States and Canadian Academy of Pathology (USCAP) Annual Meeting

Poster presentation highlights efficacy of advanced AI H&E image analysis grading and phenotyping platform to predict risk of early-stage breast cancer recurrence NEW YORK, March 8, 2023 /PRNewswire/ -- PreciseDx, a leading innovator in AI-powered, patient-specific disease analysis, today...